AAAAAA
Results: 26-50/54
Authors:
Manzambi, JK
Tellier, V
Bertrand, F
Albert, A
Reginster, JY
Van Balen, H
Citation: Jk. Manzambi et al., Determinants of health care utilization in an African urban environment: Results of a survey in Kinshasa (Congo), TR MED I H, 5(8), 2000, pp. 563-570
Authors:
Reginster, JY
Minne, HW
Sorensen, OH
Hooper, M
Roux, C
Brandi, ML
Lund, B
Ethgen, D
Pack, S
Roumagnac, I
Eastell, R
Citation: Jy. Reginster et al., Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis, OSTEOPOR IN, 11(1), 2000, pp. 83-91
Authors:
Wuster, C
Albanese, C
De Aloysio, D
Duboeuf, F
Gambacciani, M
Gonnelli, S
Gluer, CC
Hans, D
Joly, J
Reginster, JY
De Terlizzi, F
Cadossi, R
Citation: C. Wuster et al., Phalangeal osteosonogrammetry study: Age-related changes, diagnostic sensitivity, and discrimination power, J BONE MIN, 15(8), 2000, pp. 1603-1614
Authors:
Reginster, JY
Bruyere, O
Audran, M
Avouac, B
Body, JJ
Bouvenot, G
Brandi, ML
Gennari, C
Kaufman, JM
Lemmel, EM
Vanhaelst, L
Weryha, G
Devogelaer, JP
Citation: Jy. Reginster et al., Do estrogens effectively prevent osteoporosis-related fractures?, CALCIF TIS, 67(3), 2000, pp. 191-194
Authors:
Fogelman, I
Ribot, C
Smith, R
Ethgen, D
Sod, E
Reginster, JY
Citation: I. Fogelman et al., Risedronate reverses bone loss in postmenopausal women with low bone mass:Results from a multinational, double-blind, placebo-controlled trial, J CLIN END, 85(5), 2000, pp. 1895-1900
Authors:
Kaufman, JM
Johnell, O
Abadie, E
Adami, S
Audran, M
Avouac, B
Ben Sedrine, W
Calvo, G
Devogelaer, JP
Fuchs, V
Kreutz, G
Nilsson, P
Pols, H
Ringe, J
Van Haelst, L
Reginster, JY
Citation: Jm. Kaufman et al., Background for studies on the treatment of male osteoporosis: state of theart, ANN RHEUM D, 59(10), 2000, pp. 765-772
Authors:
Reginster, JY
Taquet, AN
Bruyere, OA
Citation: Jy. Reginster et al., Skeletal effects of selective oestrogen receptor modulators (SERMs), SERMS: A NOVEL OPTION TO MAINTAIN HEALTH IN THE POSTMENOPAUSE, 2000, pp. 49-61
Authors:
Halkin, V
Reginster, JY
Citation: V. Halkin et Jy. Reginster, Calcitonin, MANAGEMENT OF FRACTURES IN SEVERELY OSTEOPOROTIC BONE, 2000, pp. 437-442
Authors:
Reginster, JY
Gillet, P
Ben Sedrine, W
Brands, G
Ethgen, O
de Froidmont, C
Gosset, C
Citation: Jy. Reginster et al., Direct costs of hip fractures in patients over 60 years of age in Belgium, PHARMACOECO, 15(5), 1999, pp. 507-514
Authors:
Slosman, DO
Provvedini, DM
Meunier, PJ
Delmas, PD
Sebert, JL
De Vernejoul, MC
Tsouderos, Y
Reginster, JY
Citation: Do. Slosman et al., The use of different dual X-ray absorptiometry brands in a multicenter clinical trial - Consequences and limits, J CLIN DENS, 2(1), 1999, pp. 37-44
Authors:
Pelletier, JP
Reginster, JY
Citation: Jp. Pelletier et Jy. Reginster, The influence of tissular cross-talking on osteoarthritis progression: Role of nonsteroidal antiinflammatory drugs, OSTEO CART, 7(3), 1999, pp. 306-307
Authors:
Henrotin, Y
Reginster, JY
Citation: Y. Henrotin et Jy. Reginster, Anabolic events in osteoarthritis, OSTEO CART, 7(3), 1999, pp. 310-312
Authors:
Henrotin, Y
Reginster, JY
Citation: Y. Henrotin et Jy. Reginster, In-vitro differences among nonsteroidal antiinflammatory drugs in their activities related to osteoarthritis pathophysiology, OSTEO CART, 7(3), 1999, pp. 355-357
Authors:
Reginster, JY
Agnusdei, D
Gennari, C
Kicovic, PM
Citation: Jy. Reginster et al., Association of tibolone and fluoride displays a pronounced effect on bone mineral density in postmenopausal osteoporotic women, GYNECOL END, 13(5), 1999, pp. 361-368
Authors:
Reginster, JY
Deroisy, R
Pirenne, H
Frederick, I
Dewe, W
Albert, A
Collette, J
Zheng, SX
Gosset, C
Citation: Jy. Reginster et al., High prevalence of low femoral bone mineral density in elderly women living in nursing homes or community-dwelling: A plausible role of increased parathyroid hormone secretion, OSTEOPOR IN, 9(2), 1999, pp. 121-128
Authors:
Reginster, JY
Halkin, V
Henrotin, Y
Gosset, C
Citation: Jy. Reginster et al., Treatment of osteoporosis: Role of bone-forming agents, OSTEOPOR IN, 9, 1999, pp. 91-96
Authors:
Reginster, JY
Kuntz, D
Verdickt, W
Wouters, M
Guillevin, L
Menkes, CJ
Nielsen, K
Citation: Jy. Reginster et al., Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis, OSTEOPOR IN, 9(1), 1999, pp. 75-81
Authors:
Lips, P
Cooper, C
Agnusdei, D
Caulin, F
Egger, P
Johnell, O
Kanis, JA
Kellingray, S
Leplege, A
Liberman, UA
McCloskey, E
Minne, H
Reeve, J
Reginster, JY
Scholz, M
Todd, C
de Vernejoul, MC
Wiklund, I
Citation: P. Lips et al., Quality of life in patients with vertebral fractures: Validation of the quality of life questionnaire of the European Foundation for Osteoporosis (QUALEFFO), OSTEOPOR IN, 10(2), 1999, pp. 150-160
Authors:
Reginster, JY
Deroisy, R
Paul, I
Hansenne, M
Ansseau, M
Citation: Jy. Reginster et al., Depressive vulnerability is not an independent risk factor for osteoporosis in postmenopausal women, MATURITAS, 33(2), 1999, pp. 133-137
Authors:
Goemaere, S
Zegels, B
Toye, K
Cremer, S
Demuynck, R
Daems, M
Dobbelaere, K
Ben Sedrine, W
Albert, A
Dewe, W
Kaufman, JM
Reginster, JY
Citation: S. Goemaere et al., Limited clinical utility of a self-evaluating risk assessment scale for postmenopausal osteoporosis: Lack of predictive value of lifestyle-related factors, CALCIF TIS, 65(5), 1999, pp. 354-358
Authors:
Reginster, JY
de Froidmont, C
Lecart, MP
Sarlet, N
Defraigne, JO
Citation: Jy. Reginster et al., Alphacalcidol in prevention of glucocorticoid-induced osteoporosis, CALCIF TIS, 65(4), 1999, pp. 328-331
Recommendations for the registration of drugs intended for use in the treatment of male osteoporosis
Authors:
Kaufman, JM
Compston, J
Audran, MA
Avouac, B
Devogelaer, JP
Lemmel, EM
Vanhaelst, L
Reginster, JY
Citation: Jm. Kaufman et al., Recommendations for the registration of drugs intended for use in the treatment of male osteoporosis, CALCIF TIS, 65(1), 1999, pp. 4-7
Authors:
Brown, JP
Hosking, DJ
Ste-Marie, LG
Johnston, CC
Reginster, JY
Ryan, WG
Johnson, TD
Bekker, PJ
Citation: Jp. Brown et al., Risedronate, a highly effective, short-term oral treatment for Paget's disease: A dose-response study, CALCIF TIS, 64(2), 1999, pp. 93-99
Authors:
Gabriel, A
Detilleux, J
Jolly, S
Reginster, JY
Collin, B
Dessy-Doize, C
Citation: A. Gabriel et al., Morphometric study of the equine navicular bone: age-related changes and influence of exercise, VET RES COM, 23(1), 1999, pp. 15-40
Authors:
Gillet, P
Reginster, JY
Citation: P. Gillet et Jy. Reginster, Increased number of hip fractures, LANCET, 353(9170), 1999, pp. 2160-2161